Life sciences news
-
Estelle® oral contraceptive now available in the United States
Monday June 21st 2021
Read more
-
Mithra completes recruitment of Covid-19 Phase II Study
Thursday June 17th 2021
Read more
-
Biotalys’ ongoing trial program demonstrates strong potential of its new generation protein-based biocontrols
Thursday June 17th 2021
Read more
-
argenx announces publication of Phase 3 ADAPT trial results of efgartigimod for the treatment of generalized myasthenia gravis in The Lancet Neurology
Thursday June 17th 2021
Read more
-
Biocair moves into new Frankfurt office, continuing global expansion
Thursday June 17th 2021
Read more
-
Commercial Agency Agreement between Ardena and South Korean company Keyfronbio Co., Ltd.
Wednesday June 16th 2021
Read more
-
Biotalys announces intention to launch an Initial Public Offering on Euronext Brussels
Tuesday June 15th 2021
Read more
-
Vacature: Manager Studiedienst (m/v/x) bij flanders.bio
Monday June 14th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Montis Biosciences awarded VLAIO grant to expand its pipeline of novel immune-oncology therapeutics
Monday June 14th 2021
Read more
-
Precigen ActoBio announces positive topline results from Phase 1b/2a Study of AG019 ActoBiotics™
Monday June 14th 2021
Read more
-
OXURION confirms Institutional Review Board approval and submission of the Investigational New Drug Application to the FDA to start Phase 2 Study evaluating THR-687 for Diabetic Macular Edema (DME)
Thursday June 10th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
